Retinoblastoma Biomarker Study

Clinical trial NCT00342797 · COMPLETED

Trial details

NCT number: NCT00342797
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Study type: OBSERVATIONAL

Retinoblastoma Melanoma Sarcoma

Start date: 1993-11-17
Primary completion: 2024-03-06
Enrollment: 2136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.